Daniele Caracciolo

6.0k total citations
121 papers, 4.0k citations indexed

About

Daniele Caracciolo is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Daniele Caracciolo has authored 121 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 45 papers in Hematology and 42 papers in Molecular Biology. Recurrent topics in Daniele Caracciolo's work include Lymphoma Diagnosis and Treatment (35 papers), Hematopoietic Stem Cell Transplantation (21 papers) and Multiple Myeloma Research and Treatments (18 papers). Daniele Caracciolo is often cited by papers focused on Lymphoma Diagnosis and Treatment (35 papers), Hematopoietic Stem Cell Transplantation (21 papers) and Multiple Myeloma Research and Treatments (18 papers). Daniele Caracciolo collaborates with scholars based in Italy, United States and United Kingdom. Daniele Caracciolo's co-authors include Pierfrancesco Tassone, G Rovera, M Valtieri, Corrado Tarella, D Santoli, Nicola Amodio, Maria Teresa Di Martino, Pierosandro Tagliaferri, Fulvio Mavilio and Giada Juli and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Daniele Caracciolo

118 papers receiving 3.9k citations

Peers

Countries citing papers authored by Daniele Caracciolo

Since Specialization

Citations

This map shows the geographic impact of Daniele Caracciolo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniele Caracciolo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniele Caracciolo more than expected).

Fields of papers citing papers by Daniele Caracciolo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniele Caracciolo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniele Caracciolo. The network helps show where Daniele Caracciolo may publish in the future.

Co-authorship network of co-authors of Daniele Caracciolo

This figure shows the co-authorship network connecting the top 25 collaborators of Daniele Caracciolo. A scholar is included among the top collaborators of Daniele Caracciolo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniele Caracciolo. Daniele Caracciolo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CD19 CAR-T Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Retrospective Cohort Study from the Calabria Referral Center in Southern Italy 2025 ·Cancers ·Daniele Caracciolo, (unknown), (unknown), Caterina Alati, (unknown), Gaetana Porto, (unknown), (unknown), (unknown), Alessandro Allegra, Demetrio Gerace, Michele Cimminiello, (unknown), Pierosandro Tagliaferri, Pierfrancesco Tassone, Massimo Martino	0
2	Severe Hemodynamic Instability in a Young Pregnant Woman with Massive Pericardial Effusion and Pulmonary Embolism Secondary to Primary Mediastinal Non-Hodgkin’s Lymphoma 2025 ·Journal of Clinical Medicine ·(unknown), (unknown), (unknown), (unknown), (unknown), Nadia Salerno, (unknown), Giuseppe Filiberto Serraino, Daniele Caracciolo, Roberta Venturella, Daniele Torella, Pasquale Mastroroberto, Marco Chiappetta, Alessandro Russo, Pierosandro Tagliaferri, Pierfrancesco Tassone, Fulvio Zullo, Andrea Bruni, Federico Longhini, Eugenio Garofalo	0
3	An unbiased lncRNA dropout CRISPR-Cas9 screen reveals RP11-350G8.5 as a novel therapeutic target for multiple myeloma 2024 ·Blood ·Katia Grillone, (unknown), Paolo Cremaschi, Jussara Amato, Nicoletta Polerà, Ottavio Croci, Roberta Rocca, Caterina Riillo, Francesco Conforti, (unknown), Diego Brancaccio, Daniele Caracciolo, Stefano Alcaro, Bruno Pagano, Antonio Randazzo, Pierosandro Tagliaferri, Francesco Iorio, Pierfrancesco Tassone	10
4	TERRA G‐quadruplex stabilization behind the anti‐multiple myeloma activity: Novel insights about resveratrol pleiotropic effects 2024 ·Archiv der Pharmazie ·Roberta Rocca, (unknown), (unknown), Francesca Scionti, Giada Juli, Maria Teresa Di Martino, Daniele Caracciolo, Anna Artese, Pierosandro Tagliaferri, Pierfrancesco Tassone, Katia Grillone, Stefano Alcaro	1
5	UMG1/CD3ε‐bispecific T‐cell engager redirects T‐cell cytotoxicity against diffuse large B‐cell lymphoma 2023 ·British Journal of Haematology ·Daniele Caracciolo, Nicoletta Polerà, Beatrice Belmonte, Francesco Conforti, (unknown), Alessandro Gulino, Nicoletta Staropoli, Franca Maria Tuccillo, Patrizia Bonelli, Giada Juli, Katia Grillone, (unknown), (unknown), (unknown), Andrea Ballerini, Cristina Pelizon, Maria Teresa Di Martino, Pierosandro Tagliaferri, Caterina Riillo, Pierfrancesco Tassone	1
6	The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas 2023 ·Cancers ·Nicoletta Polerà, Antonia Mancuso, Caterina Riillo, Daniele Caracciolo, (unknown), Katia Grillone, (unknown), Craig A. Hokanson, Francesco Conforti, Nicoletta Staropoli, (unknown), Maria Teresa Di Martino, Mariamena Arbitrio, (unknown), Roberto Crea, Pierosandro Tagliaferri, Giada Juli, Pierfrancesco Tassone	1
7	TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 2023 ·Journal of Experimental & Clinical Cancer Research ·Francesca Scionti, Giada Juli, Roberta Rocca, Nicoletta Polerà, Matteo Nadai, Katia Grillone, Daniele Caracciolo, Caterina Riillo, Emanuela Altomare, (unknown), (unknown), (unknown), Mariamena Arbitrio, Sara N. Richter, Anna Artese, Stefano Alcaro, Pierosandro Tagliaferri, Pierfrancesco Tassone, Maria Teresa Di Martino	14
8	The emerging scenario of immunotherapy for T-cell Acute Lymphoblastic Leukemia: advances, challenges and future perspectives 2023 ·Experimental Hematology and Oncology ·Daniele Caracciolo, Antonia Mancuso, Nicoletta Polerà, (unknown), (unknown), Caterina Riillo, Pierosandro Tagliaferri, Pierfrancesco Tassone	15
9	The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma 2022 ·International Journal of Molecular Sciences ·Katia Grillone, Caterina Riillo, Roberta Rocca, (unknown), Virginia Spanò, Francesca Scionti, Nicoletta Polerà, Annalisa Maruca, Marilia Barreca, Giada Juli, Mariamena Arbitrio, Maria Teresa Di Martino, Daniele Caracciolo, Pierosandro Tagliaferri, Stefano Alcaro, Alessandra Montalbano, Paola Barraja, Pierfrancesco Tassone	32
10	A drug repurposing screening reveals a novel epigenetic activity of hydroxychloroquine 2019 ·European Journal of Medicinal Chemistry ·Raffaella Catalano, Roberta Rocca, Giada Juli, Giosuè Costa, Annalisa Maruca, Anna Artese, Daniele Caracciolo, Pierosandro Tagliaferri, Stefano Alcaro, Pierfrancesco Tassone, Nicola Amodio	27
11	Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma 2019 ·Cancers ·Nicola Amodio, Maria Eugenia Gallo Cantafio, Cirino Botta, Valter Agosti, Cinzia Federico, Daniele Caracciolo, Domenica Ronchetti, Marco Rossi, Christoph Driessen, Antonino Neri, Pierosandro Tagliaferri, Pierfrancesco Tassone	35
12	MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches 2018 ·Journal of Hematology & Oncology ·Nicola Amodio, Lavinia Raimondi, Giada Juli, Maria Angelica Stamato, Daniele Caracciolo, Pierosandro Tagliaferri, Pierfrancesco Tassone	258
13	Th17 Cells Targeting By MiR-21 Inhibitor Impairs Multiple Myeloma Related Bone Disease 2017 ·Blood ·Marco Rossi, Emanuela Altomare, Nicola Amodio, Maria Teresa Di Martino, Marco Gaspari, Domenico Taverna, Domenica Scumaci, Francesco Conforti, Daniele Caracciolo, Cirino Botta, Cinzia Federico, Annamaria Gullà, Eugenio Morelli, Francesca Scionti, Mariamena Arbitrio, (unknown), Antonino Neri, Pierosandro Tagliaferri, Pierfrancesco Tassone	2
14	Rate of Primary Refractory Disease in B and T-Cell Non-Hodgkin’s Lymphoma: Correlation with Long-Term Survival 2014 ·PLoS ONE ·Corrado Tarella, Angela Gueli, Federica Delaini, Andrea Rossi, Anna Maria Barbui, Giuseppe Gritti, Cristina Boschini, Daniele Caracciolo, Riccardo Bruna, Marco Ruella, Daniela Gottardi, Roberto Passera, Alessandro Rambaldi	17
15	Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphoma 2013 ·Annals of Hematology ·Simone Ferrero, Luigia Monitillo, Barbara Mantoan, Daniela Barbero, Elisa Genuardi, (unknown), (unknown), Daniele Caracciolo, Marco Ruella, Daniela Drandi, Manuela Zanni, (unknown), Chiara Lobetti Bodoni, Angela Gueli, Roberto Passera, Pellegrino Musto, Mario Boccadoro, Corrado Tarella, Marco Ladetto	10
16	SERUM FREE LIGHT CHAINS (SFLC) ASSAY: A SUGGESTIVE NEW CRITERIA FOR EVALUATING DISEASE RESPONSE, PROGRESSION AND RELAPSE IN PLASMA-CELL DISORDERS (PD) AND A PROGNOSTIC FACTOR IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS) 2006 ·Haematologica ·(unknown), Luisa Giaccone, Daniele Caracciolo, Benedetto Bruno, (unknown), Paola Omedè, Silvano Battaglio, (unknown), Christian Sfiligoi, Francesco Fiore, (unknown), Mario Boccadoro	1
17	Long-term follow-up of advanced-stage low-grade lymphoma patients treated upfront with high-dose sequential chemotherapy and autograft 2000 ·Leukemia ·Corrado Tarella, Daniele Caracciolo, Paolo Corradini, Francesco Zallio, Marco Ladetto, Alessandra Cuttica, Giuseppe Rossi, Domenico Novero, Paolo Gavarotti, Alessandro Pileri	35
18	Differential activity of recombinant colony‐stimulating factors in supporting proliferation of human peripheral blood and bone marrow myeloid progenitors in culture 1989 ·British Journal of Haematology ·Daniele Caracciolo, Steven C. Clark, G Rovera	37
19	Recombinant human macrophage colony-stimulating factor (M-CSF) requires subliminal concentrations of granulocyte/macrophage (GM)-CSF for optimal stimulation of human macrophage colony formation in vitro. 1987 ·The Journal of Experimental Medicine ·Daniele Caracciolo, Neelam Shirsat, G Wong, Beverly J. Lange, Stephen Clark, G Rovera	79
20	Tumor‐derived Growth Factors That Support Proliferation and Differentiation of Normal and Leukemic Hemopoietic Cells 1987 ·Annals of the New York Academy of Sciences ·David J. Tweardy, Daniele Caracciolo, M Valtieri, G Rovera	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact